Enrolling by invitation NCT07217730

Healthcare Integrity & Anti-Fraud Enforcement

— Observational Healthcare Fraud Schemes Kickback Networks Supply Chain Vulnerabilities Governance Failures

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Validator-Governed Reform & Regulatory Escalation Protocol, Coalition-Grade Validator Dashboard Module (CVDM-1), Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1).
Who it may be relevant to: Registry conditions: Healthcare Fraud Schemes, Kickback Networks, Supply Chain Vulnerabilities, Governance Failures. Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: United States
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

§ PHX-AFK-US: Public Health Exchange Protocol for Anti-Fraud, Kickback Prevention & Secure Chain Integrity in U.S. Healthcare Facilities

Overview

The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.

Detailed description

Interventions

Other Validator-Governed Reform & Regulatory Escalation Protocol
This intervention deploys a validator-governed framework to monitor, escalate, and reform healthcare facilities exhibiting fraud, kickback schemes, and supply chain vulnerabilities. It integrates notarized affidavits, smart contract enforcement, NFT fiscal declarations, and DAO voting logic to trigger sanctions, regulatory complaints, and operational restructuring. Facilities are observed prospectively, with all actions logged to a public dashboard and anchored via SHA-256 hash notarization. No
Device Coalition-Grade Validator Dashboard Module (CVDM-1)
The Coalition-Grade Validator Dashboard Module (CVDM-1) is a secure, web-based device deployed across enrolled healthcare facilities to enable real-time validator oversight, whistleblower affidavit intake, and smart contract enforcement. It integrates QR-linked audit trails, NFT fiscal declarations, and DAO voting logic. The device anchors all inputs via SHA-256 hash notarization and transmits reform metrics to coalition dashboards. CVDM-1 supports public transparency, regulatory escalation, and
Drug Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)
The Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1) is a governance-based drug intervention targeting facilities with suspected fraud, kickback schemes, or supply chain irregularities involving pharmaceuticals. While not a therapeutic agent, CFPAT-1 functions as a regulatory scaffold that flags drug procurement, formulary manipulation, and referral-linked prescribing patterns. It integrates validator ballots, smart contract logic, and SHA-256 hash anchors to escalate complaints to CMS,

Primary outcome measures

Change in Fraudulent Billing and Kickback Incidents Across Enrolled Facilities [Time frame: Baseline to 12 Months Post-Validator Onboarding]

Secondary outcome measures (1)

Change in Supply-Chain Traceability and Compliance Across Enrolled Facilities [Time frame: Baseline to 12 Months Post-Validator Onboarding]

Eligibility criteria

Inclusion criteria

Facility has documented billing, compliance, or procurement irregularities.

Facility participates in coalition validator onboarding and SHA-256 protocol enrollment.

Facility provides access to billing, procurement, and whistleblower-anchored datasets for auditing.

Exclusion criteria

Facility refuses validator onboarding or coalition integration.

Facility lacks traceable procurement or compliance records.

Facility has no whistleblower declaration or validation artifact.

Facility operates outside U.S. jurisdiction or coalition-recognized governance zones.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model: Cohort

Study locations

United States · 1 center

Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016 — New York

Identifiers

NCT: NCT07217730 · PRS-HI-AFK-SC-US-101325-GS

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗